Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

January 25, 2028

Study Completion Date

February 25, 2028

Conditions
Post-Surgical Pain, ChronicPost-traumatic Pain, Chronic
Interventions
DEVICE

Peripheral Transcutaneous Magnetic Stimulation from MagVenture

"MagVenture Pain Therapy System: It is an FDA-cleared magnetic stimulator system that provides brief and focused magnetic pulses to non-invasively stimulate peripheral nerves and provide relief of chronic intractable, post-traumatic, and post-surgical pain for patients 18 years or older. It is a relatively new technique in the US for pain relief in the clinical setting and thus not very widespread yet. Evidence shows Magnetic Peripheral Nerve Stimulation to have a promising average pain relief of up to 87%\*. Using magnetic pulses, MagVenture Pain Therapy engages sensory, pain, and motor fibers mechanistically to recondition the central nervous system by eliminating noxious pain signals to the brain, reducing chronic neuropathic pain for responsive patients.~\*Bedder M, Parker L.: Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain, 2023"

Trial Locations (1)

33199

RECRUITING

Ambulatory Care Center, Florida International University, Miami

All Listed Sponsors
collaborator

Baptist Health South Florida

OTHER

lead

Florida International University

OTHER